866-997-4948(US-Canada Toll Free)

United States Anticoagulant Drug Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 103 Pages

In this report, the United States Anticoagulant Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Anticoagulant Drug in these regions, from 2012 to 2022 (forecast).

United States Anticoagulant Drug market competition by top manufacturers/players, with Anticoagulant Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Jansen pharmaceuticals
Boehringer Ingelheim
Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson
...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Unfractionated Heparin
Direct Inhibition Inhibitors
Low Molecular Weight Heparin
Factor XA Inhibitors
Warfarin
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Anticoagulant Drug for each application, including
Hospitals
Clinics
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Anticoagulant Drug Market Report 2017
1 Anticoagulant Drug Overview
1.1 Product Overview and Scope of Anticoagulant Drug
1.2 Classification of Anticoagulant Drug by Product Category
1.2.1 United States Anticoagulant Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Anticoagulant Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Unfractionated Heparin
1.2.4 Direct Inhibition Inhibitors
1.2.5 Low Molecular Weight Heparin
1.2.6 Factor XA Inhibitors
1.2.7 Warfarin
1.3 United States Anticoagulant Drug Market by Application/End Users
1.3.1 United States Anticoagulant Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 United States Anticoagulant Drug Market by Region
1.4.1 United States Anticoagulant Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Anticoagulant Drug Status and Prospect (2012-2022)
1.4.3 Southwest Anticoagulant Drug Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Anticoagulant Drug Status and Prospect (2012-2022)
1.4.5 New England Anticoagulant Drug Status and Prospect (2012-2022)
1.4.6 The South Anticoagulant Drug Status and Prospect (2012-2022)
1.4.7 The Midwest Anticoagulant Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anticoagulant Drug (2012-2022)
1.5.1 United States Anticoagulant Drug Sales and Growth Rate (2012-2022)
1.5.2 United States Anticoagulant Drug Revenue and Growth Rate (2012-2022)

2 United States Anticoagulant Drug Market Competition by Players/Suppliers
2.1 United States Anticoagulant Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anticoagulant Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anticoagulant Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Anticoagulant Drug Market Competitive Situation and Trends
2.4.1 United States Anticoagulant Drug Market Concentration Rate
2.4.2 United States Anticoagulant Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anticoagulant Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Anticoagulant Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Anticoagulant Drug Sales and Market Share by Region (2012-2017)
3.2 United States Anticoagulant Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Anticoagulant Drug Price by Region (2012-2017)

4 United States Anticoagulant Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Anticoagulant Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anticoagulant Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Anticoagulant Drug Price by Type (2012-2017)
4.4 United States Anticoagulant Drug Sales Growth Rate by Type (2012-2017)

5 United States Anticoagulant Drug Sales (Volume) by Application (2012-2017)
5.1 United States Anticoagulant Drug Sales and Market Share by Application (2012-2017)
5.2 United States Anticoagulant Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Anticoagulant Drug Players/Suppliers Profiles and Sales Data
6.1 Jansen pharmaceuticals
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Anticoagulant Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Jansen pharmaceuticals Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim
6.2.2 Anticoagulant Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Boehringer Ingelheim Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Sanofi
6.3.2 Anticoagulant Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sanofi Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Bristol-Myers Squibb
6.4.2 Anticoagulant Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bristol-Myers Squibb Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bayer
6.5.2 Anticoagulant Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bayer Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Johnson & Johnson
6.6.2 Anticoagulant Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Johnson & Johnson Anticoagulant Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
...

7 Anticoagulant Drug Manufacturing Cost Analysis
7.1 Anticoagulant Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anticoagulant Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Anticoagulant Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anticoagulant Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Anticoagulant Drug Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Anticoagulant Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anticoagulant Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Anticoagulant Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Anticoagulant Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Anticoagulant Drug
Figure United States Anticoagulant Drug Market Size (MT) by Type (2012-2022)
Figure United States Anticoagulant Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Unfractionated Heparin Product Picture
Figure Direct Inhibition Inhibitors Product Picture
Figure Low Molecular Weight Heparin Product Picture
Figure Factor XA Inhibitors Product Picture
Figure Warfarin Product Picture
Figure United States Anticoagulant Drug Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Anticoagulant Drug by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Anticoagulant Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Anticoagulant Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anticoagulant Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anticoagulant Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anticoagulant Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anticoagulant Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anticoagulant Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anticoagulant Drug Sales (MT) and Growth Rate (2012-2022)
Figure United States Anticoagulant Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anticoagulant Drug Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Anticoagulant Drug Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Anticoagulant Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anticoagulant Drug Sales Share by Players/Suppliers
Figure 2017 United States Anticoagulant Drug Sales Share by Players/Suppliers
Figure United States Anticoagulant Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anticoagulant Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anticoagulant Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anticoagulant Drug Revenue Share by Players/Suppliers
Figure 2017 United States Anticoagulant Drug Revenue Share by Players/Suppliers
Table United States Market Anticoagulant Drug Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Anticoagulant Drug Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Anticoagulant Drug Market Share of Top 3 Players/Suppliers
Figure United States Anticoagulant Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anticoagulant Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anticoagulant Drug Product Category
Table United States Anticoagulant Drug Sales (MT) by Region (2012-2017)
Table United States Anticoagulant Drug Sales Share by Region (2012-2017)
Figure United States Anticoagulant Drug Sales Share by Region (2012-2017)
Figure United States Anticoagulant Drug Sales Market Share by Region in 2016
Table United States Anticoagulant Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anticoagulant Drug Revenue Share by Region (2012-2017)
Figure United States Anticoagulant Drug Revenue Market Share by Region (2012-2017)
Figure United States Anticoagulant Drug Revenue Market Share by Region in 2016
Table United States Anticoagulant Drug Price (USD/Kg) by Region (2012-2017)
Table United States Anticoagulant Drug Sales (MT) by Type (2012-2017)
Table United States Anticoagulant Drug Sales Share by Type (2012-2017)
Figure United States Anticoagulant Drug Sales Share by Type (2012-2017)
Figure United States Anticoagulant Drug Sales Market Share by Type in 2016
Table United States Anticoagulant Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anticoagulant Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anticoagulant Drug by Type (2012-2017)
Figure Revenue Market Share of Anticoagulant Drug by Type in 2016
Table United States Anticoagulant Drug Price (USD/Kg) by Types (2012-2017)
Figure United States Anticoagulant Drug Sales Growth Rate by Type (2012-2017)
Table United States Anticoagulant Drug Sales (MT) by Application (2012-2017)
Table United States Anticoagulant Drug Sales Market Share by Application (2012-2017)
Figure United States Anticoagulant Drug Sales Market Share by Application (2012-2017)
Figure United States Anticoagulant Drug Sales Market Share by Application in 2016
Table United States Anticoagulant Drug Sales Growth Rate by Application (2012-2017)
Figure United States Anticoagulant Drug Sales Growth Rate by Application (2012-2017)
Table Jansen pharmaceuticals Basic Information List
Table Jansen pharmaceuticals Anticoagulant Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Jansen pharmaceuticals Anticoagulant Drug Sales Growth Rate (2012-2017)
Figure Jansen pharmaceuticals Anticoagulant Drug Sales Market Share in United States (2012-2017)
Figure Jansen pharmaceuticals Anticoagulant Drug Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anticoagulant Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Anticoagulant Drug Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Anticoagulant Drug Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Anticoagulant Drug Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Anticoagulant Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Anticoagulant Drug Sales Growth Rate (2012-2017)
Figure Sanofi Anticoagulant Drug Sales Market Share in United States (2012-2017)
Figure Sanofi Anticoagulant Drug Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Anticoagulant Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Anticoagulant Drug Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Anticoagulant Drug Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Anticoagulant Drug Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Anticoagulant Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bayer Anticoagulant Drug Sales Growth Rate (2012-2017)
Figure Bayer Anticoagulant Drug Sales Market Share in United States (2012-2017)
Figure Bayer Anticoagulant Drug Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Anticoagulant Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Anticoagulant Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Anticoagulant Drug Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Anticoagulant Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anticoagulant Drug
Figure Manufacturing Process Analysis of Anticoagulant Drug
Figure Anticoagulant Drug Industrial Chain Analysis
Table Raw Materials Sources of Anticoagulant Drug Major Players/Suppliers in 2016
Table Major Buyers of Anticoagulant Drug
Table Distributors/Traders List
Figure United States Anticoagulant Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Anticoagulant Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anticoagulant Drug Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Anticoagulant Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Anticoagulant Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Anticoagulant Drug Sales Volume (MT) Forecast by Type in 2022
Table United States Anticoagulant Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Anticoagulant Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Anticoagulant Drug Sales Volume (MT) Forecast by Application in 2022
Table United States Anticoagulant Drug Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Anticoagulant Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anticoagulant Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anticoagulant Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *